Education
About Us
Working with TipRanks
Follow Us
Relmada Therapeutics (RLMD)
NASDAQ:RLMD
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -59.10M | $ -83.89M | $ -103.70M | $ -161.25M | $ -125.70M |
| EBITDA | $ -59.10M | $ -83.89M | $ 4.91M | $ -161.25M | $ -125.70M |
| Net Income | $ -57.39M | $ -79.98M | $ -98.79M | $ -157.04M | $ -125.75M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 93.01M | $ 44.91M | $ 96.32M | $ 148.32M | $ 211.91M |
| Total Assets | $ 94.00M | $ 45.82M | $ 97.55M | $ 152.91M | $ 223.33M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -3.50M | $ -3.86M | $ -4.09M | $ -5.40M | $ -44.44M |
| Total Liabilities | $ 7.49M | $ 10.30M | $ 12.19M | $ 12.47M | $ 15.06M |
| Stockholders' Equity | $ 86.51M | $ 35.52M | $ 85.36M | $ 140.44M | $ 208.26M |
| Cash Flow | |||||
| Free Cash Flow | $ -45.79M | $ -51.76M | $ -51.66M | $ -103.80M | $ -91.87M |
| Operating Cash Flow | $ -45.79M | $ -51.76M | $ -51.66M | $ -103.80M | $ -91.87M |
| Investing Cash Flow | $ -48.14M | $ 51.56M | $ 50.45M | $ 19.73M | $ -54.12M |
| Financing Cash Flow | $ 93.56M | $ -40.34K | $ -98.46K | $ 45.02M | $ 187.94M |